<a href="http://www.kaisernetwork.org/daily_reports/rep_index.cfm"><img src="http://www.kaisernetwork.org/images/index_flash_headlines.gif" width="437" height="42" border=0></a>
Features
Session Webcasts
Daily Update
Highlights
Newsmakers
Frontlines
Resources
Daily HIV/AIDS Report
Webcasts on HIV/AIDS
Public Opinion on HIV/AIDS Issues
Kaiser Family
Foundation- HIV/AIDS Policy
XIV International AIDS
Conference Website
More Resources
FAQ
Special Coverage: Home
Special Coverage: XIV International AIDS Conference
Resources
Trimeris
Roche
Merck & Company, Inc.
Barcelona, Spain, July 7 - 12, 2002
New Treatments for HIV/AIDS
Dani Bolognesi, CEO of Trimeris, and James Tomass from Roche discuss T-20, an emerging treatment for HIV/AIDS
(
Windows Media
)
(
Real
)
(
Transcript
)
Animation provided by Roche illustrates the HIV lifecycle and the effects of fusion inhibitor drugs
(
Windows Media
)
(
Real
)
Daria Hazuda, from Merck & Company, talks about integrase inhibitor treatments
(
Windows Media
)
(
Real
)
(
Transcript
)
More Newsmakers
( 
( 
